Quest Diagnostics Incorporated (DGX) is expected to report earnings on Tuesday, October 20, 2026, before the open. Estimated release time 02:47 ET. Consensus EPS estimate is $2.85.
| Report date | Quarter | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|---|
| 2026-07-23 | FY2026 Q2 | $2.82 | $3.12 | +10.6% | $3.04B |
| 2026-04-21 | FY2026 Q1 | $2.37 | $2.50 | +5.5% | $2.90B |
| 2026-02-10 | FY2025 Q4 | $2.36 | $2.42 | +2.5% | $2.81B |
| 2025-10-21 | FY2025 Q3 | $2.50 | $2.60 | +4.0% | $2.82B |
| 2025-07-22 | FY2025 Q2 | $2.57 | $2.62 | +1.9% | $2.76B |
| 2025-04-22 | FY2025 Q1 | $2.15 | $2.21 | +2.8% | $2.65B |
| 2025-01-30 | FY2024 Q4 | $2.19 | $2.23 | +1.8% | $2.62B |
| 2024-10-22 | FY2024 Q3 | $2.26 | $2.30 | +1.8% | $2.49B |
DGX has beaten consensus EPS in 8 of its last 8 reported quarters.
See DGX on the live calendar →